Linagliptin 5.00 mg + Empagliflozin 25.00 mg

LINARES E is a fixed-dose combination medication that contains Linagliptin and Empagliflozin. Linagliptin belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors, which help lower blood sugar levels by increasing the insulin release and decreasing glucose production. Empagliflozin is a sodium-glucose co-transporter-2 (SGLT-2) inhibitor that works by blocking the reabsorption of glucose in the kidneys, leading to its elimination through urine. This combination medication is used in the management of type 2 diabetes mellitus to improve glycemic control. LINARES E is prescribed as an adjunct to lifestyle modifications, including diet and exercise, for better glucose control.

Take LINARES E orally once daily, with or without food, as directed by your doctor. It is important to follow your doctor's instructions and monitor blood sugar levels regularly.

Allopathic

The contents and information provided here are solely intended to provide a general overview of the products and medicines and must be used for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. The information contained herein should not be used as a substitute for the advice of a qualified physician. For all queries or doubts related to your medical condition, we highly recommend that you consult your registered medical practitioner.